MoneyWorks4Me

Biocon informs about quarterly statement of investor complaints

07 Jan 2017 Evaluate

Biocon has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1786.15
Dr. Reddys Labs. 1197.60
Cipla 1336.40
Lupin 2012.10
Zydus Lifesciences 1143.50
View more..